Guizhi Fuling Decoction inhibiting the PI3K and MAPK pathways in breast cancer cells revealed by HTS2 technology and systems pharmacology

Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 68, 394, 10.3322/caac.21492 Adams, 2007, The use of complementary and alternative medicine by cancer patients, Int Semin Surg Oncol, 4 Wang, 2015, Effects of traditional Chinese medicine in treatment of breast cancer patients after mastectomy: A meta-analysis, Cell Biochem Biophys, 71, 1299, 10.1007/s12013-014-0348-z Su, 2015, Main progress on studies of pharmacological activities and clinical applications of Guizhi Fuling capsule, China J Chin Mater Med, 40, 989 Ziru, 2018, Effect of Guizhi Fuling capsule and its ingredients on human breast cancer cells proliferation, Chin J Integr Trad West Med, 38, 202 Songlin, 2015, The effect of Guizhifuling Decoction on related protein of the mitochondrial pathway of apoptosis of breast cancer cell lines and cell cycle, Guid J Trad Chin Med Pharm, 21, 23 Huang, 2014, Systems pharmacology in drug discovery and therapeutic insight for herbal medicines, Brief Bioinf, 15, 710, 10.1093/bib/bbt035 Dai, 2018, A new strategy to uncover the anticancer mechanism of chinese compound formula by integrating systems pharmacology and bioinformatics, Evid-Based Complementary Altern Med, 2018, 6707850, 10.1155/2018/6707850 Shao, 2019, Chemical genomics reveals inhibition of breast cancer lung metastasis by Ponatinib via c-Jun, Protein Cell, 10, 161, 10.1007/s13238-018-0533-8 Li, 2012, Versatile pathway-centric approach based on high-throughput sequencing to anticancer drug discovery, PNAS, 109, 4609, 10.1073/pnas.1200305109 Ru, 2014, TCMSP: a database of systems pharmacology for drug discovery from herbal medicines, J Cheminform, 6, 13, 10.1186/1758-2946-6-13 Kim, 2016, PubChem substance and compound databases, Nucleic Acids Res, 44, D1202, 10.1093/nar/gkv951 Xu, 2012, A novel chemometric method for the prediction of human oral bioavailability, Int J Mol Sci, 13, 6964, 10.3390/ijms13066964 Tao, 2013, Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease, J Ethnopharmacol, 145, 1, 10.1016/j.jep.2012.09.051 Yu, 2012, A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data, PLoS ONE, 7 Szklarczyk, 2016, STITCH 5: Augmenting protein-chemical interaction networks with tissue and affinity data, Nucleic Acids Res, 44, D380, 10.1093/nar/gkv1277 Yang, 2016, Therapeutic target database update 2016: Enriched resource for bench to clinical drug target and targeted pathway information, Nucleic Acids Res, 44, D1069, 10.1093/nar/gkv1230 Bateman, 2017, UniProt: The universal protein knowledgebase, Nucleic Acids Res, 46, 2699 Hamosh, 2000, Online Mendelian Inheritance in Man (OMIM), Hum Mutat, 15, 57, 10.1002/(SICI)1098-1004(200001)15:1<57::AID-HUMU12>3.0.CO;2-G Wishart, 2018, DrugBank 5.0: A major update to the DrugBank database for 2018, Nucleic Acids Res, 46, D1074, 10.1093/nar/gkx1037 Shannon, 2003, Cytoscape: A software environment for integrated models of biomolecular interaction networks, Genome Res, 13, 2498, 10.1101/gr.1239303 Huang, 2009, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources, Nat Protoc, 4, 44, 10.1038/nprot.2008.211 R Development Core Team R. R: A Language and Environment for Statistical Computing. 2011. Cerami, 2012, The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data, Cancer Disc, 2, 401, 10.1158/2159-8290.CD-12-0095 Li, 2012, RASL-seq for massively parallel and quantitative analysis of gene expression, Curr Prot Mol Biol, 98 Ogata, 2000, KEGG: Kyoto encyclopedia of genes and genomes, Nucleic Acids Res, 28, 27, 10.1093/nar/28.1.27 Love, 2014, Differential analysis of count data – the DESeq2 package, Genome Biol, 15, 10 Kolde R. pheatmap : Pretty Heatmaps. R Package Version 108 2015. Ginestet, 2011, ggplot2: elegant graphics for data analysis, J R Stat Soc: Ser A (Stat Soc), 174, 245, 10.1111/j.1467-985X.2010.00676_9.x Szklarczyk, 2019, STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets, Nucleic Acids Res, 47, D607, 10.1093/nar/gky1131 Györffy, 2010, An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients, Breast Cancer Res Treat, 123, 725, 10.1007/s10549-009-0674-9 Berman, 2002, The protein data bank, Acta Crystallogr D Biol Crystallogr, 58, 899, 10.1107/S0907444902003451 Schrödinger. Maestro | Schrödinger. Schrödinger Release 2018-1 2018. Friesner, 2006, Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes, J Med Chem, 49, 6177, 10.1021/jm051256o Van Der Spoel, 2005, GROMACS: Fast, flexible, and free, J Comput Chem, 26, 1701, 10.1002/jcc.20291 DeLano WL. Pymol: An open-source molecular graphics tool. CCP4 Newsletter On Protein Crystallography 2002;40:82–92. Chisholm, 2016, Cell population heterogeneity and evolution towards drug resistance in cancer: biological and mathematical assessment, theoretical treatment optimisation, Biochim Biophys Acta – Gen Subj, 1860, 2627, 10.1016/j.bbagen.2016.06.009 Kohoutova, 2018, Mitotic and apoptotic activity in colorectal neoplasia, BMC Gastroenterol, 18, 65, 10.1186/s12876-018-0786-y Chio, 2017, ROS in cancer: the burning question, Trends Mol Med, 23, 411, 10.1016/j.molmed.2017.03.004 Reddy, 2015, MicroRNA (miRNA) in cancer, Cancer Cell Int, 15, 38, 10.1186/s12935-015-0185-1 Iozzo, 2011, Proteoglycans in cancer biology, tumour microenvironment and angiogenesis, J Cell Mol Med, 15, 1013, 10.1111/j.1582-4934.2010.01236.x Garusi, 2012, Antithetic roles of proteoglycans in cancer, Cell Mol Life Sci, 69, 553, 10.1007/s00018-011-0816-1 You, 2018, Unique dependence on Sos1 in KrasG12D-induced leukemogenesis, Blood, 132, 2575, 10.1182/blood-2018-09-874107 Durrant, 2011, Molecular dynamics simulations and drug discovery, BMC Biol, 9, 71, 10.1186/1741-7007-9-71 Wu, 2018, The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation article, Cell Death Dis, 9, 232, 10.1038/s41419-018-0267-9 Yan, 2018, Baicalein induces apoptosis and autophagy of breast cancer cells via inhibiting PI3K/AKT pathway in vivo and vitro, Drug Des Dev Ther, 12, 3961, 10.2147/DDDT.S181939 Ding, 2018, Effect of long non-coding RNA H19 on oxidative stress and chemotherapy resistance of CD133+ cancer stem cells via the MAPK/ERK signaling pathway in hepatocellular carcinoma, Biochem Biophys Res Commun, 502, 194, 10.1016/j.bbrc.2018.05.143 Zheng, 2017, Metapristone suppresses non-small cell lung cancer proliferation and metastasis via modulating RAS/RAF/MEK/MAPK signaling pathway, Biomed Pharmacother, 90, 437, 10.1016/j.biopha.2017.03.091 Ke, 2017, Crude terpene glycoside component from Radix paeoniae rubra protects against isoproterenol-induced myocardial ischemic injury via activation of the PI3K/AKT/mTOR signaling pathway, J Ethnopharmacol, 12, 160, 10.1016/j.jep.2017.05.028 Han, 2016, Guizhi Fuling Wan, a traditional Chinese herbal formula, sensitizes cisplatin-resistant human ovarian cancer cells through inactivation of the PI3K/AKT/mTOR Pathway, Evid-Based Complementary Altern Med, 2016, 4651949, 10.1155/2016/4651949 Wu, 2016, Breast cancer invasion and metastasis by mPRα through the PI3K/Akt signaling pathway, Pathol Oncol Res, 22, 471, 10.1007/s12253-015-0023-8 Fan, 2018, Casticin inhibits breast cancer cell migration and invasion by downregulation of PI3K/Akt signaling pathway, Biosci Rep, 38, 10.1042/BSR20180738 Zhong, 2017, Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway, Tumor Biol, 1 Moradzadeh, 2017, Epigallocatechin-3-gallate promotes apoptosis in human breast cancer T47D cells through down-regulation of PI3K/AKT and Telomerase, Pharmacol Rep, 69, 924, 10.1016/j.pharep.2017.04.008 Miao, 2017, MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway, Sci Rep, 7, 41942, 10.1038/srep41942 Yang, 2017, DEK promoted EMT and angiogenesis through regulating PI3K/ AKT/mTOR pathway in triple-negative breast cancer, Oncotarget, 8, 98708, 10.18632/oncotarget.21864 Bachman, 2004, The PIK3CA gene is mutated with high frequency in human breast cancers, Cancer Biol Ther, 3, 772, 10.4161/cbt.3.8.994 Yang, 2017, CCL28 promotes breast cancer growth and metastasis through MAPK-mediated cellular anti-apoptosis and pro-metastasis, Oncol Rep, 38, 1393, 10.3892/or.2017.5798 Chen, 2018, miR-3188 regulates cell proliferation, apoptosis, and migration in breast cancer by targeting TUSC5 and regulating the p38 MAPK signaling pathway, Oncol Res, 26, 363, 10.3727/096504017X14953948675421 Fan, 2017, Dalbergia odorifera extract promotes angiogenesis through upregulation of VEGFRs and PI3K/MAPK signaling pathways, J Ethnopharmacol, 204, 132, 10.1016/j.jep.2017.04.006 Kjaer, 2018, Prognostic and predictive value of EGFR and EGFR-ligands in blood of breast cancer patients: A systematic review, Clin Chem Lab Med, 56, 688, 10.1515/cclm-2017-0592 Alanazi, 2016, Understanding EGFR signaling in breast cancer and breast cancer stem cells: Overexpression and therapeutic implications, Asian Pac J Cancer Prev, 17, 445, 10.7314/APJCP.2016.17.2.445 Chiosea, 2015, Molecular characterization of apocrine salivary duct carcinoma, Am J Surg Pathol, 39, 744, 10.1097/PAS.0000000000000410 Chiosea, 2014, HRAS mutations in epithelial-myoepithelial carcinoma, Head Neck Pathol, 8, 146, 10.1007/s12105-013-0506-4 Xiao, 2016, Expressions of Ras and Sos1 in epithelial ovarian cancer tissues and their clinical significance, J South Med Univ, 36, 1502 Cai, 2019, Identification and characterization of oncogenic SOS1 mutations in lung adenocarcinoma, Mol Cancer Res, 17, 1002, 10.1158/1541-7786.MCR-18-0316 Lin, 2018, MicroRNA 628 suppresses migration and invasion of breast cancer stem cells through targeting SOS1, OncoTargets Ther, 11, 5419, 10.2147/OTT.S164575 Li, 2017, Expression of long non-coding RNA linc-ITGB1 in breast cancer and its influence on prognosis and survival, Eur Rev Med Pharmacol Sci, 21, 3397 Tancioni, 2015, FAK activity protects nucleostemin in facilitating breast cancer spheroid and tumor growth, Breast Cancer Res, 17, 47, 10.1186/s13058-015-0551-x Woo, 2017, Daurinol blocks breast and lung cancer metastasis and development by inhibition of focal adhesion kinase, (FAK). Oncotarget, 8, 57058, 10.18632/oncotarget.18983